New study tests personalised care to combat brain fog in Graves' disease
NCT ID NCT06309316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a person-centred care (PCC) programme, delivered by phone and online, can help people with Graves' disease feel better mentally and return to work. 220 adults with first-time Graves' disease will be randomly assigned to receive either usual care or usual care plus PCC for 12-18 months. The main goal is to see if PCC improves self-efficacy and reduces sick leave after 3 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
person-centred care (PCC) via phone and web platform
What this could lead to
If it works, this could offer a practical, non-drug way to reduce mental fatigue and sick leave for people with Graves' disease, and may be applied to other conditions.
What could go wrong
This is a relatively small, early-stage trial testing a behavioural intervention, not a drug. The effect may be modest, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Agneta Lindo
RECRUITINGGothenburg, 413 45, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact